| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 ATP7B IPO8 MYO5A MYO7B LONP2 ABCA12 ABCA13 MYO19 PEX1 KIF12 SRPRA FANCM DDX6 ORC1 DQX1 RECQL4 KIF19 HFM1 MYO15A | 3.59e-07 | 614 | 172 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 6.28e-07 | 3 | 172 | 3 | GO:0005220 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH3 ATP7B LONP2 ABCA12 ABCA13 MYO19 PEX1 KIF12 SRPRA FANCM DDX6 ORC1 DQX1 RECQL4 KIF19 HFM1 | 1.43e-06 | 441 | 172 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.36e-05 | 118 | 172 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | kinase binding | PRKD2 ERBB2 ANK2 MYO5A POLA1 RAB11FIP2 CCND1 PFKFB1 PTAFR OPA1 PTK2 MAPK8IP3 IQGAP1 SIRPG MLKL CSPG4 PKD1 SYN1 PLCB4 MAPK4 MAPK6 | 9.41e-05 | 969 | 172 | 21 | GO:0019900 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DNAH3 ATP7B LONP2 ABCA12 ABCA13 MYO19 PEX1 KIF12 SRPRA RAB20 FANCM OPA1 DDX6 ORC1 DQX1 RECQL4 KIF19 HFM1 | 1.31e-04 | 775 | 172 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.79e-04 | 33 | 172 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | protein kinase binding | PRKD2 ERBB2 ANK2 MYO5A POLA1 RAB11FIP2 CCND1 PTAFR PTK2 MAPK8IP3 IQGAP1 SIRPG MLKL CSPG4 PKD1 SYN1 PLCB4 MAPK4 MAPK6 | 1.96e-04 | 873 | 172 | 19 | GO:0019901 |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 2.13e-04 | 14 | 172 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.14e-04 | 140 | 172 | 7 | GO:0099094 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 3.12e-04 | 38 | 172 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DNAH3 ATP7B LONP2 ABCA12 ABCA13 MYO19 PEX1 KIF12 SRPRA RAB20 FANCM OPA1 DDX6 ORC1 DQX1 RECQL4 KIF19 HFM1 | 3.45e-04 | 839 | 172 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DNAH3 ATP7B LONP2 ABCA12 ABCA13 MYO19 PEX1 KIF12 SRPRA RAB20 FANCM OPA1 DDX6 ORC1 DQX1 RECQL4 KIF19 HFM1 | 3.50e-04 | 840 | 172 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DNAH3 ATP7B LONP2 ABCA12 ABCA13 MYO19 PEX1 KIF12 SRPRA RAB20 FANCM OPA1 DDX6 ORC1 DQX1 RECQL4 KIF19 HFM1 | 3.50e-04 | 840 | 172 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 4.38e-04 | 4 | 172 | 2 | GO:0008390 | |
| GeneOntologyMolecularFunction | 6-phosphofructo-2-kinase activity | 4.38e-04 | 4 | 172 | 2 | GO:0003873 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 4.66e-04 | 18 | 172 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | small GTPase binding | IPO8 RGPD8 MYO5A MYCBP2 RAB11FIP2 RAB11FIP1 IQGAP1 GGA3 APPL2 HACE1 | 4.84e-04 | 321 | 172 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 7.25e-04 | 5 | 172 | 2 | GO:0050649 | |
| GeneOntologyMolecularFunction | fructose-2,6-bisphosphate 2-phosphatase activity | 7.25e-04 | 5 | 172 | 2 | GO:0004331 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 7.25e-04 | 5 | 172 | 2 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 7.25e-04 | 5 | 172 | 2 | GO:0062181 | |
| GeneOntologyMolecularFunction | short-chain fatty acid transmembrane transporter activity | 7.25e-04 | 5 | 172 | 2 | GO:0015636 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ATP7B GRM7 SLC40A1 ITPR1 ITPR2 ITPR3 SLC9A3 KCNA10 KCNH2 CATSPER4 PKD1 KCNT1 | 7.26e-04 | 465 | 172 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 8.33e-04 | 49 | 172 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | calcium channel activity | 8.89e-04 | 129 | 172 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 1.08e-03 | 6 | 172 | 2 | GO:0030343 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 1.08e-03 | 6 | 172 | 2 | GO:0070576 | |
| GeneOntologyMolecularFunction | four-way junction helicase activity | 1.08e-03 | 6 | 172 | 2 | GO:0009378 | |
| GeneOntologyMolecularFunction | GTPase binding | IPO8 RGPD8 MYO5A MYCBP2 RAB11FIP2 RAB11FIP1 IQGAP1 GGA3 APPL2 HACE1 | 1.16e-03 | 360 | 172 | 10 | GO:0051020 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.45e-03 | 193 | 172 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | phosphofructokinase activity | 1.51e-03 | 7 | 172 | 2 | GO:0008443 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 1.51e-03 | 7 | 172 | 2 | GO:0070643 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.62e-03 | 197 | 172 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | transporter activity | SLC22A25 ATP7B IPO8 ABCA12 ABCA13 PEX1 XKR8 SLC22A24 GRM7 SLC40A1 GGA3 ITPR1 ITPR2 ITPR3 SLC22A9 SLC9A3 KCNA10 KCNH2 CATSPER4 PKD1 GJA10 KCNT1 | 1.66e-03 | 1289 | 172 | 22 | GO:0005215 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.99e-03 | 151 | 172 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 2.00e-03 | 8 | 172 | 2 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 2.00e-03 | 8 | 172 | 2 | GO:0034875 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 2.00e-03 | 8 | 172 | 2 | GO:0101021 | |
| GeneOntologyMolecularFunction | myosin light chain binding | 2.00e-03 | 8 | 172 | 2 | GO:0032027 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.36e-03 | 31 | 172 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.98e-03 | 343 | 172 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | actin binding | KLHL1 MYO5A MYO7B MYO19 PTK2 IQGAP1 ARPC2 SYNE2 SYN1 MYO15A MYBPC3 | 2.99e-03 | 479 | 172 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | SPATA6L KLHL1 ANK2 MYO5A MYO7B MYO19 IFT81 KIF12 OPA1 PTK2 MAPK8IP3 IQGAP1 ARPC2 DLC1 SYNE2 KIF19 SYN1 MYO15A MYBPC3 | 3.01e-03 | 1099 | 172 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 3.09e-03 | 34 | 172 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | sugar-phosphatase activity | 3.17e-03 | 10 | 172 | 2 | GO:0050308 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase binding | 3.36e-03 | 35 | 172 | 3 | GO:0051019 | |
| GeneOntologyMolecularFunction | aromatase activity | 3.36e-03 | 35 | 172 | 3 | GO:0070330 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | PRKD2 ERBB2 RIOK1 HTATIP2 CCND1 PFKFB1 PFKFB3 PTK2 MLKL TIE1 PIP5K1B MAPK4 MAPK6 MAP2K5 | 3.38e-03 | 709 | 172 | 14 | GO:0016773 |
| GeneOntologyMolecularFunction | carbohydrate phosphatase activity | 3.86e-03 | 11 | 172 | 2 | GO:0019203 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 3.86e-03 | 11 | 172 | 2 | GO:0101020 | |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 4.60e-03 | 12 | 172 | 2 | GO:0019534 | |
| GeneOntologyMolecularFunction | lipid binding | SESTD1 CYP3A4 CYP3A43 FFAR3 GPR42 ARHGAP26 PEX1 PTAFR OPA1 IQGAP1 GGA3 ITPR1 ITPR2 ITPR3 SLC9A3 DLC1 APPL2 | 5.20e-03 | 988 | 172 | 17 | GO:0008289 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | ZSWIM8 ANK2 TBL1Y PRAMEF22 PRAMEF19 ARHGAP26 HTATIP2 PEX1 CCND1 TBL1XR1 MAPK8IP3 IQGAP1 ANKRD13A BEND6 SYNE2 SYN1 BRD1 MED26 MED13 | 5.37e-03 | 1160 | 172 | 19 | GO:0030674 |
| GeneOntologyMolecularFunction | MAP-kinase scaffold activity | 5.41e-03 | 13 | 172 | 2 | GO:0005078 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 4.36e-05 | 9 | 171 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 8.46e-05 | 11 | 171 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | motile cilium | ADCY10 DNAH3 PRAMEF22 PRAMEF19 IFT81 DDX6 DNAAF5 CATSPER4 PKD1 CFAP45 VPS13A | 1.71e-04 | 355 | 171 | 11 | GO:0031514 |
| GeneOntologyCellularComponent | 9+2 non-motile cilium | 1.83e-04 | 14 | 171 | 3 | GO:0097732 | |
| GeneOntologyCellularComponent | kinocilium | 1.83e-04 | 14 | 171 | 3 | GO:0060091 | |
| GeneOntologyCellularComponent | concave side of sperm head | 1.99e-04 | 3 | 171 | 2 | GO:0061830 | |
| GeneOntologyCellularComponent | cilium | ADCY10 DNAH3 MYO5A PRAMEF22 PRAMEF19 IFT81 CDH23 PTK2 DDX6 DNAAF5 CATSPER4 KIF19 PKD1 CFAP45 VPS13A ANKMY2 STRC STRCP1 | 4.19e-04 | 898 | 171 | 18 | GO:0005929 |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 5.40e-04 | 46 | 171 | 4 | GO:0005790 | |
| GeneOntologyCellularComponent | stereocilium tip | 7.39e-04 | 22 | 171 | 3 | GO:0032426 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ERBB2 ABCA12 ABCA13 ARHGAP26 UBR4 RAB11FIP2 CC2D1A PTAFR RAB11FIP1 RAB20 IQGAP1 GGA3 ITPR1 ITPR2 ARPC2 ITPR3 SLC9A3 APPL2 PKD1 VPS13A SYN1 SEC23B | 1.02e-03 | 1307 | 171 | 22 | GO:0030659 |
| GeneOntologyCellularComponent | basal part of cell | ADCY10 ERBB2 SLC22A25 ATP7B ANK2 SLC40A1 PTK2 IQGAP1 SLC22A9 PKD1 | 1.14e-03 | 378 | 171 | 10 | GO:0045178 |
| GeneOntologyCellularComponent | vesicle membrane | ERBB2 ABCA12 ABCA13 ARHGAP26 UBR4 RAB11FIP2 CC2D1A PTAFR RAB11FIP1 RAB20 IQGAP1 GGA3 ITPR1 ITPR2 ARPC2 ITPR3 SLC9A3 APPL2 PKD1 VPS13A SYN1 SEC23B | 1.22e-03 | 1325 | 171 | 22 | GO:0012506 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.32e-03 | 320 | 171 | 9 | GO:0016323 | |
| GeneOntologyCellularComponent | myosin complex | 1.39e-03 | 59 | 171 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | ruffle | 1.57e-03 | 206 | 171 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | 90S preribosome | 1.68e-03 | 29 | 171 | 3 | GO:0030686 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ADCY10 ERBB2 ATP7B ANK2 RGPD8 CISD2 TRAIP XKR8 PTK2 DDX6 MAPK8IP3 ITPR1 ITPR3 ANKRD13A KCNH2 PPM1F SEC23B | 1.74e-03 | 934 | 171 | 17 | GO:0048471 |
| GeneOntologyCellularComponent | leading edge membrane | 1.75e-03 | 210 | 171 | 7 | GO:0031256 | |
| MousePheno | abnormal somatic nervous system physiology | 1.25e-06 | 83 | 134 | 8 | MP:0005423 | |
| MousePheno | abnormal sensory neuron physiology | 5.57e-06 | 72 | 134 | 7 | MP:0010055 | |
| Domain | P-loop_NTPase | ADCY10 DNAH3 MYO5A MYO7B LONP2 ABCA12 ABCA13 MYO19 PEX1 KIF12 SRPRA PFKFB1 PFKFB3 RAB20 FANCM OPA1 DDX6 IQGAP1 ORC1 DQX1 RECQL4 KIF19 HFM1 MYO15A | 5.59e-07 | 848 | 167 | 24 | IPR027417 |
| Domain | InsP3_rcpt-bd | 7.02e-07 | 3 | 167 | 3 | IPR000493 | |
| Domain | - | ADCY10 DNAH3 MYO7B LONP2 ABCA12 ABCA13 MYO19 PEX1 SRPRA PFKFB1 PFKFB3 RAB20 FANCM OPA1 DDX6 ORC1 DQX1 RECQL4 HFM1 MYO15A | 1.19e-05 | 746 | 167 | 20 | 3.40.50.300 |
| Domain | RIH_assoc-dom | 1.38e-05 | 6 | 167 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.38e-05 | 6 | 167 | 3 | PF08709 | |
| Domain | RIH_assoc | 1.38e-05 | 6 | 167 | 3 | PF08454 | |
| Domain | RIH_dom | 1.38e-05 | 6 | 167 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.38e-05 | 6 | 167 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.38e-05 | 6 | 167 | 3 | IPR015925 | |
| Domain | - | 1.38e-05 | 6 | 167 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.38e-05 | 6 | 167 | 3 | PF01365 | |
| Domain | CXorf40 | 7.95e-05 | 2 | 167 | 2 | IPR033615 | |
| Domain | MIR | 8.05e-05 | 10 | 167 | 3 | PF02815 | |
| Domain | MIR_motif | 8.05e-05 | 10 | 167 | 3 | IPR016093 | |
| Domain | MIR | 8.05e-05 | 10 | 167 | 3 | PS50919 | |
| Domain | MIR | 8.05e-05 | 10 | 167 | 3 | SM00472 | |
| Domain | ASCH_domain | 2.37e-04 | 3 | 167 | 2 | IPR007374 | |
| Domain | ASCH | 2.37e-04 | 3 | 167 | 2 | SM01022 | |
| Domain | MAPK_ERK3/4 | 2.37e-04 | 3 | 167 | 2 | IPR008350 | |
| Domain | ARM-type_fold | IPO8 UBR4 USP24 HSF2BP PSMD5 ITPR1 ITPR2 DNAAF5 SF3B1 MROH7 UTP20 | 2.44e-04 | 339 | 167 | 11 | IPR016024 |
| Domain | AAA | 3.17e-04 | 144 | 167 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 3.17e-04 | 144 | 167 | 7 | IPR003593 | |
| Domain | Myosin_head_motor_dom | 3.59e-04 | 38 | 167 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.59e-04 | 38 | 167 | 4 | PS51456 | |
| Domain | Myosin_head | 3.59e-04 | 38 | 167 | 4 | PF00063 | |
| Domain | MYSc | 3.59e-04 | 38 | 167 | 4 | SM00242 | |
| Domain | 6Phosfructo_kin | 4.71e-04 | 4 | 167 | 2 | IPR013079 | |
| Domain | GPR40-rel_orph | 4.71e-04 | 4 | 167 | 2 | IPR013312 | |
| Domain | 6Pfruct_kin | 4.71e-04 | 4 | 167 | 2 | IPR003094 | |
| Domain | 6PF2K | 4.71e-04 | 4 | 167 | 2 | PF01591 | |
| Domain | Ion_trans_dom | 5.62e-04 | 114 | 167 | 6 | IPR005821 | |
| Domain | Ion_trans | 5.62e-04 | 114 | 167 | 6 | PF00520 | |
| Domain | PUA-like_domain | 6.12e-04 | 19 | 167 | 3 | IPR015947 | |
| Domain | - | 7.16e-04 | 20 | 167 | 3 | 3.40.50.1240 | |
| Domain | His_PPase_superfam | 7.16e-04 | 20 | 167 | 3 | IPR029033 | |
| Domain | Cyt_P450_E_grp-II | 7.81e-04 | 5 | 167 | 2 | IPR002402 | |
| Domain | IQ | 7.97e-04 | 81 | 167 | 5 | SM00015 | |
| Domain | RBD-FIP | 1.16e-03 | 6 | 167 | 2 | PF09457 | |
| Domain | Cyt_P450_E_CYP3A | 1.16e-03 | 6 | 167 | 2 | IPR008072 | |
| Domain | Rab-bd_FIP-RBD | 1.16e-03 | 6 | 167 | 2 | IPR019018 | |
| Domain | FIP_RBD | 1.16e-03 | 6 | 167 | 2 | PS51511 | |
| Domain | IQ_motif_EF-hand-BS | 1.28e-03 | 90 | 167 | 5 | IPR000048 | |
| Domain | IQ | 1.48e-03 | 93 | 167 | 5 | PS50096 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.19e-06 | 10 | 125 | 4 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.85e-06 | 11 | 125 | 4 | M49033 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 3.96e-06 | 13 | 125 | 4 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 6.72e-06 | 5 | 125 | 3 | M49000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 1.34e-05 | 6 | 125 | 3 | M47960 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 2.56e-05 | 20 | 125 | 4 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 3.14e-05 | 21 | 125 | 4 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.81e-05 | 22 | 125 | 4 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.81e-05 | 22 | 125 | 4 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.58e-05 | 23 | 125 | 4 | M47676 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 5.50e-05 | 9 | 125 | 3 | M47852 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 7.79e-05 | 50 | 125 | 5 | M47951 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 1.07e-04 | 11 | 125 | 3 | M27466 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.82e-04 | 13 | 125 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 1.82e-04 | 13 | 125 | 3 | M47751 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.82e-04 | 13 | 125 | 3 | MM14553 | |
| Pathway | WP_GPR40_PATHWAY | 2.86e-04 | 15 | 125 | 3 | M39526 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 3.50e-04 | 16 | 125 | 3 | M26945 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 5.04e-04 | 18 | 125 | 3 | MM14843 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 5.08e-04 | 42 | 125 | 4 | M791 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 5.65e-04 | 76 | 125 | 5 | M9052 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 5.94e-04 | 19 | 125 | 3 | M27423 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 5.94e-04 | 19 | 125 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 5.94e-04 | 19 | 125 | 3 | M47733 | |
| Pubmed | ZSWIM8 MYO5A MYCBP2 POLA1 UBR4 NOL6 USP24 LARP4 GFPT1 IQGAP1 ITPR3 SF3B1 SUPT6H SYNE2 OASL UTP20 MPHOSPH10 SEC23B | 4.92e-09 | 653 | 172 | 18 | 22586326 | |
| Pubmed | SESTD1 ANK2 RGPD8 MYO5A MYCBP2 TBL1Y UBR4 HECTD4 TBL1XR1 OPA1 PTK2 MAPK8IP3 IQGAP1 ARPC2 SIRPG SF3B1 TMEM259 SYNE2 SYN1 PLCL1 KCNT1 | 1.47e-08 | 963 | 172 | 21 | 28671696 | |
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 10874040 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 20395455 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 17437169 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 18547250 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 36350267 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 11413485 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 26009177 | ||
| Pubmed | Receptor-activated single channels in intact human platelets. | 1.19e-07 | 3 | 172 | 3 | 1693919 | |
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 23955339 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 31979185 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 1.19e-07 | 3 | 172 | 3 | 24904548 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 1.19e-07 | 3 | 172 | 3 | 9858485 | |
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 9808793 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 18194433 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 1.19e-07 | 3 | 172 | 3 | 27777977 | |
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 1.19e-07 | 3 | 172 | 3 | 17581770 | |
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 1.19e-07 | 3 | 172 | 3 | 18241669 | |
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 19068129 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 17327232 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 16014380 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 17890015 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 1.19e-07 | 3 | 172 | 3 | 23983250 | |
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 20427533 | ||
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 25215520 | ||
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 11163362 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 4.74e-07 | 4 | 172 | 3 | 21424589 | |
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 28615414 | ||
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 10828023 | ||
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 28419336 | ||
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 4.74e-07 | 4 | 172 | 3 | 35494252 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PRKD2 ERBB2 MYCBP2 ARHGAP26 UBR4 HECTD4 CC2D1A AHDC1 MAPK8IP3 GGA3 ITPR2 ITPR3 ORC1 NHSL1 TMEM259 KCNH2 CSPG4 PKD1 CRAMP1 MED13 | 6.45e-07 | 1105 | 172 | 20 | 35748872 |
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 7.56e-07 | 15 | 172 | 4 | 28578927 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DNAH3 MXRA5 TAS1R3 POLA1 MYO19 UBR4 SRPRA GFPT1 ITPR2 IGSF10 DQX1 RECQL4 PKD1 VPS13A CSTF2 UTP20 | 8.83e-07 | 736 | 172 | 16 | 29676528 |
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 1.18e-06 | 5 | 172 | 3 | 21568942 | |
| Pubmed | 1.18e-06 | 5 | 172 | 3 | 24920589 | ||
| Pubmed | PRKD2 SESTD1 ZSWIM8 ANK2 MYO5A MYCBP2 IFT81 UBR4 MCF2L2 HECTD4 PSMD5 GFPT1 PTK2 MAPK8IP3 IQGAP1 NPRL2 SF3B1 APPL2 PKD1 ST18 MED13 | 1.70e-06 | 1285 | 172 | 21 | 35914814 | |
| Pubmed | 2.35e-06 | 6 | 172 | 3 | 23463619 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 2.35e-06 | 6 | 172 | 3 | 25966694 | |
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 2.35e-06 | 6 | 172 | 3 | 21762810 | |
| Pubmed | 2.35e-06 | 6 | 172 | 3 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 2.35e-06 | 6 | 172 | 3 | 16844763 | |
| Pubmed | IPO8 CISD2 MYO19 UBR4 NOL6 SRPRA CCND1 PSMD13 PFKFB3 DDX6 IQGAP1 ITPR1 ITPR2 ARPC2 ITPR3 ANKRD13A DNAAF5 SF3B1 COMMD4 TMEM259 SYNE2 OASL | 2.81e-06 | 1440 | 172 | 22 | 30833792 | |
| Pubmed | ERBB2 RIOK1 KLHL1 USP24 CCND1 TBL1XR1 GFPT1 PTK2 KCNA10 KCNH2 PLCL1 MAPK4 MAPK6 MAP2K5 SEC23B | 3.90e-06 | 730 | 172 | 15 | 34857952 | |
| Pubmed | 4.10e-06 | 7 | 172 | 3 | 11860456 | ||
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 4.10e-06 | 7 | 172 | 3 | 22495310 | |
| Pubmed | 5.68e-06 | 24 | 172 | 4 | 10843712 | ||
| Pubmed | ATP7B MYO5A MYCBP2 CISD2 LONP2 ACP2 UBR4 HTATIP2 CC2D1A PSMD13 LARP4 OPA1 DDX6 ITPR1 ITPR2 ITPR3 RECQL4 OASL MED13 | 5.85e-06 | 1168 | 172 | 19 | 19946888 | |
| Pubmed | Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane. | 6.54e-06 | 8 | 172 | 3 | 21165971 | |
| Pubmed | 6.54e-06 | 8 | 172 | 3 | 17714910 | ||
| Pubmed | ERBB2 UBR4 SRPRA CCND1 PFKFB3 IQGAP1 ITPR1 ITPR2 ITPR3 TIMELESS MPHOSPH10 RNF145 | 8.60e-06 | 503 | 172 | 12 | 36217030 | |
| Pubmed | 9.77e-06 | 9 | 172 | 3 | 25737585 | ||
| Pubmed | 1.25e-05 | 29 | 172 | 4 | 32123907 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | MYCBP2 NOL6 HECTD4 LARP4 GFPT1 DDX6 ITPR1 ITPR2 ITPR3 SUPT6H MPHOSPH10 | 1.34e-05 | 440 | 172 | 11 | 34244565 |
| Pubmed | 1.90e-05 | 11 | 172 | 3 | 31776257 | ||
| Pubmed | Type 1 and 3 inositol trisphosphate receptors are required for extra-embryonic vascular development. | 1.90e-05 | 11 | 172 | 3 | 27514653 | |
| Pubmed | MXRA5 ARHGAP26 UBR4 NOL6 USP24 GFPT1 ITPR3 TMEM156 PPM1F SYNE2 VPS13A HFM1 MPHOSPH10 | 1.92e-05 | 638 | 172 | 13 | 31182584 | |
| Pubmed | CCDC14 MYO5A MYCBP2 SRPRA PSMD13 HID1 RAB11FIP1 OPA1 ITPR1 ITPR2 ITPR3 NHSL1 PHKB PPM1F SYNE2 VPS13A CSTF2 | 1.95e-05 | 1049 | 172 | 17 | 27880917 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | CISD2 UBR4 USP24 PEX1 SRPRA OPA1 GFPT1 IQGAP1 ITPR3 ANKRD13A DNAAF5 TMEM259 PPM1F CSTF2 UTP20 TIMELESS | 1.97e-05 | 942 | 172 | 16 | 31073040 |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 25637492 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 30478340 | ||
| Pubmed | Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. | 2.43e-05 | 2 | 172 | 2 | 9065779 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 20715157 | ||
| Pubmed | Intestinal FFA3 mediates obesogenic effects in mice on a Western diet. | 2.43e-05 | 2 | 172 | 2 | 35858247 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 15890645 | ||
| Pubmed | ANK2 functionally interacts with KCNH2 aggravating long QT syndrome in a double mutation carrier. | 2.43e-05 | 2 | 172 | 2 | 30929919 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22506074 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 27286256 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 24748202 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 15201137 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 35819177 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 36362376 | ||
| Pubmed | Cholinergic augmentation of insulin release requires ankyrin-B. | 2.43e-05 | 2 | 172 | 2 | 20234002 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 14722080 | ||
| Pubmed | Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. | 2.43e-05 | 2 | 172 | 2 | 8081734 | |
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 2.43e-05 | 2 | 172 | 2 | 23582047 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 20399779 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 11944901 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 25002529 | ||
| Pubmed | The adrenergic-induced ERK3 pathway drives lipolysis and suppresses energy dissipation. | 2.43e-05 | 2 | 172 | 2 | 32139423 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 34910522 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 23110765 | ||
| Pubmed | The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation. | 2.43e-05 | 2 | 172 | 2 | 26522986 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 15632133 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 18237245 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 27664183 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 7559486 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 20843799 | ||
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 2.43e-05 | 2 | 172 | 2 | 19120126 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 14689059 | ||
| Pubmed | Effect of small interfering RNA transfection on FAK and DLC1 mRNA expression in OVCAR-3. | 2.43e-05 | 2 | 172 | 2 | 22760257 | |
| Pubmed | Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers. | 2.43e-05 | 2 | 172 | 2 | 16490596 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 37019194 | ||
| Pubmed | Rab11-dependent Recycling of the Human Ether-a-go-go-related Gene (hERG) Channel. | 2.43e-05 | 2 | 172 | 2 | 26152716 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 38040866 | ||
| Pubmed | Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve. | 2.43e-05 | 2 | 172 | 2 | 17496801 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 35408893 | ||
| Pubmed | FFAR3 modulates insulin secretion and global gene expression in mouse islets. | 2.43e-05 | 2 | 172 | 2 | 26091414 | |
| Pubmed | Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. | 2.43e-05 | 2 | 172 | 2 | 8663526 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 3.07e-07 | 3 | 123 | 3 | 297 | |
| GeneFamily | 6-phosphofructo-2-kinases/fructose-2,6-biphosphatases | 2.73e-04 | 4 | 123 | 2 | 1077 | |
| GeneFamily | Olfactory receptors, family 3 | 6.76e-04 | 6 | 123 | 2 | 150 | |
| GeneFamily | Cytochrome P450 family 3 | 1.25e-03 | 8 | 123 | 2 | 1002 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.50e-03 | 181 | 123 | 6 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.86e-03 | 36 | 123 | 3 | 823 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 2.43e-03 | 11 | 123 | 2 | 1168 | |
| GeneFamily | Mitogen-activated protein kinases | 3.41e-03 | 13 | 123 | 2 | 651 | |
| GeneFamily | ATP binding cassette subfamily A | 3.96e-03 | 14 | 123 | 2 | 805 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 4.77e-03 | 50 | 123 | 3 | 1293 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN | CCDC14 IPO8 HECTD4 IQGAP1 ITPR1 DNAAF5 PHKB PPM1F ZBTB40 TIMELESS | 7.63e-07 | 197 | 172 | 10 | M8271 |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | 7.37e-06 | 200 | 172 | 9 | M7839 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.33e-05 | 187 | 161 | 9 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-7|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.10e-07 | 159 | 173 | 8 | 75a82bbabd97b168dbf1c3f43a9bdad48ce18c78 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.52e-07 | 194 | 173 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | BAL-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 4.15e-06 | 167 | 173 | 7 | 6c5aa9077ae7eb8887269d405972bd5b31596b19 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-06 | 182 | 173 | 7 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-06 | 182 | 173 | 7 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.57e-06 | 183 | 173 | 7 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.13e-06 | 185 | 173 | 7 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.07e-05 | 193 | 173 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 193 | 173 | 7 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 193 | 173 | 7 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-05 | 199 | 173 | 7 | c6d59ed26eadd3c41acfe1b4d929270e00ea3e95 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 142 | 173 | 6 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.34e-05 | 156 | 173 | 6 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.42e-05 | 164 | 173 | 6 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | remission-HSPC|World / disease stage, cell group and cell class | 4.73e-05 | 166 | 173 | 6 | d269ee6f7adb55b05dcb5eaea96629ccb0b2d6e3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-05 | 169 | 173 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.40e-05 | 170 | 173 | 6 | d682178d11d67eb5a02d0c6b3967645e37bcc62a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.40e-05 | 170 | 173 | 6 | 84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b | |
| ToppCell | COVID-19_Convalescent-Hematopoietic_SC|COVID-19_Convalescent / Disease group, lineage and cell class | 5.40e-05 | 170 | 173 | 6 | 8a73d5334eed1cd9fdcc3ebeae0bdf9f945c228a | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.58e-05 | 171 | 173 | 6 | 2031797d579ce373921affad70da6e50eec13664 | |
| ToppCell | remission-HSPC|remission / disease stage, cell group and cell class | 5.58e-05 | 171 | 173 | 6 | 41b424e58470a2fc25632aea50a37c7c5ea17645 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.58e-05 | 171 | 173 | 6 | a4e13b304ef414722ffdc06560deeab41785e956 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.58e-05 | 171 | 173 | 6 | 172db31a37b72fb87fe5f0f79da51866b90dd1ad | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_Erythro-Mega|lymph-node_spleen / Manually curated celltypes from each tissue | 5.58e-05 | 171 | 173 | 6 | 3ecd0a074344179c57eb2d9a857ba594904d00fa | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.58e-05 | 171 | 173 | 6 | 1af575809b3334bfaa019ff26c56e6cb03c82ee8 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.76e-05 | 172 | 173 | 6 | 8fd3db757d54949bd583d5f0eadf63a32342cb9d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.76e-05 | 172 | 173 | 6 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.76e-05 | 172 | 173 | 6 | da78f7a71b7f05c5c484c9ed19ba37c55d35e870 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.76e-05 | 172 | 173 | 6 | 382cb5fea099110eb026a8bba6cf4c28763ea52f | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 175 | 173 | 6 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 6.54e-05 | 176 | 173 | 6 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 173 | 6 | ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 173 | 6 | f471f7747d6e8db7546899019af9508f48a14f89 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 173 | 6 | cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.75e-05 | 177 | 173 | 6 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | Children_(3_yrs)|World / Lineage, Cell type, age group and donor | 6.96e-05 | 178 | 173 | 6 | df2ecd3214590b914f2762db57efe780ba038db3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-05 | 183 | 173 | 6 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 8.36e-05 | 184 | 173 | 6 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-05 | 184 | 173 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.36e-05 | 184 | 173 | 6 | a60802e11dcc5f932811260b08a95a32f60f6b19 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.36e-05 | 184 | 173 | 6 | 39c230d32e4259bc784e0edfd9e2884c96898564 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.36e-05 | 184 | 173 | 6 | 667846c422cfa27e949a24844a305df859cb6760 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.36e-05 | 184 | 173 | 6 | 2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.36e-05 | 184 | 173 | 6 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-05 | 184 | 173 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.36e-05 | 184 | 173 | 6 | a6f8b42982ec0cf44b950a2cd9715d068eec4ecb | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-05 | 184 | 173 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.61e-05 | 185 | 173 | 6 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.61e-05 | 185 | 173 | 6 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.61e-05 | 185 | 173 | 6 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.61e-05 | 185 | 173 | 6 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.87e-05 | 186 | 173 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | 3'_v3-blood-Hematopoietic_progenitors-Progenitor_Erythro-Mega|blood / Manually curated celltypes from each tissue | 8.87e-05 | 186 | 173 | 6 | 59c115bbbb4bca4ad80be1809d8a0422b8438ea3 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.87e-05 | 186 | 173 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.14e-05 | 187 | 173 | 6 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 9.68e-05 | 189 | 173 | 6 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.68e-05 | 189 | 173 | 6 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 9.68e-05 | 189 | 173 | 6 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.97e-05 | 190 | 173 | 6 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 9.97e-05 | 190 | 173 | 6 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 193 | 173 | 6 | a189d46c39067b717509cd144e0225cc93d7731d | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 1.09e-04 | 193 | 173 | 6 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 194 | 173 | 6 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 194 | 173 | 6 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.15e-04 | 195 | 173 | 6 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.15e-04 | 195 | 173 | 6 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 195 | 173 | 6 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.15e-04 | 195 | 173 | 6 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.15e-04 | 195 | 173 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.15e-04 | 195 | 173 | 6 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.18e-04 | 196 | 173 | 6 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic-Nonclassical_monocytes|Lung / Manually curated celltypes from each tissue | 1.18e-04 | 196 | 173 | 6 | 7fe97109a5a06b35fc081a85f341ea78da131323 | |
| ToppCell | mild-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.22e-04 | 197 | 173 | 6 | 07a1f59c83b748825e0708cd1cc7b63a2cb856cc | |
| ToppCell | COVID-19-COVID-19_Convalescent-Others-HSPC|COVID-19_Convalescent / Disease, condition lineage and cell class | 1.22e-04 | 197 | 173 | 6 | c1033a1a8b8b5c8569130aa9405a6e8e65ef7bd0 | |
| ToppCell | Sigmoid-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 1.25e-04 | 198 | 173 | 6 | 305d7ae9b070ac7211638a5282374c02bf13af40 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 1.25e-04 | 198 | 173 | 6 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| ToppCell | (11)_FOXN4+|World / shred by cell type by condition | 1.25e-04 | 198 | 173 | 6 | 516b1acdf997dd8debc3dca066519366e507b414 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.28e-04 | 199 | 173 | 6 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.28e-04 | 199 | 173 | 6 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-04 | 199 | 173 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.32e-04 | 200 | 173 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.32e-04 | 200 | 173 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.32e-04 | 200 | 173 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.32e-04 | 200 | 173 | 6 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.32e-04 | 200 | 173 | 6 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.32e-04 | 200 | 173 | 6 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.32e-04 | 200 | 173 | 6 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.32e-04 | 200 | 173 | 6 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nts|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.38e-04 | 127 | 173 | 5 | ace2944328529fa029ee56c7ad3b0f283511d3bb | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.84e-04 | 135 | 173 | 5 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| Drug | geldanamycin | ERBB2 IPO8 MYO5A SRPRA CCND1 FANCM LARP4 PTK2 DDX6 IQGAP1 APPL2 KCNH2 MED13 | 4.31e-06 | 371 | 169 | 13 | ctd:C001277 |
| Drug | gabapentin | 5.00e-06 | 169 | 169 | 9 | CID000003446 | |
| Disease | pregnanediol-3-glucuronide measurement | 9.08e-06 | 8 | 163 | 3 | EFO_0800341 | |
| Disease | estrogen measurement | 1.93e-05 | 10 | 163 | 3 | EFO_0011007 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 3.03e-05 | 2 | 163 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | Hypoxic Brain Damage | 3.03e-05 | 2 | 163 | 2 | C1140716 | |
| Disease | Anoxic Encephalopathy | 3.03e-05 | 2 | 163 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 3.03e-05 | 2 | 163 | 2 | C1527348 | |
| Disease | Anoxia of brain | 3.03e-05 | 2 | 163 | 2 | C0995195 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 3.51e-05 | 12 | 163 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | conotruncal heart malformations, parental genotype effect measurement | 9.07e-05 | 3 | 163 | 2 | EFO_0005939, MONDO_0016581 | |
| Disease | 17alpha-hydroxypregnanolone glucuronide measurement | 9.07e-05 | 3 | 163 | 2 | EFO_0800363 | |
| Disease | Torsades de Pointes | 9.07e-05 | 3 | 163 | 2 | C0040479 | |
| Disease | sensory system disease (implicated_via_orthology) | 9.07e-05 | 3 | 163 | 2 | DOID:0050155 (implicated_via_orthology) | |
| Disease | androsterone glucuronide measurement | 1.76e-04 | 20 | 163 | 3 | EFO_0800317 | |
| Disease | hormone measurement, progesterone measurement | 3.00e-04 | 5 | 163 | 2 | EFO_0004730, EFO_0007004 | |
| Disease | Malignant neoplasm of breast | ERBB2 ATP7B ANK2 CYP3A4 UBR4 MCF2L2 CCND1 GGA3 PHKB SLC22A9 PPM1F SYNE2 MROH7 UTP20 TIMELESS DOP1A | 3.16e-04 | 1074 | 163 | 16 | C0006142 |
| Disease | epiandrosterone sulfate measurement | 3.48e-04 | 25 | 163 | 3 | EFO_0021120 | |
| Disease | Dwarfism | 3.48e-04 | 25 | 163 | 3 | C0013336 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 4.48e-04 | 6 | 163 | 2 | EFO_0800294 | |
| Disease | Colorectal Carcinoma | DNAH3 ATP7B ANK2 ABCA12 ABCA13 MCF2L2 CCND1 SLC22A9 DLC1 KCNA10 PPM1F VPS13A | 5.55e-04 | 702 | 163 | 12 | C0009402 |
| Disease | dehydroepiandrosterone sulphate measurement | 5.55e-04 | 68 | 163 | 4 | EFO_0007001 | |
| Disease | esophageal carcinoma | 6.02e-04 | 30 | 163 | 3 | EFO_0002916 | |
| Disease | long QT syndrome (is_implicated_in) | 6.25e-04 | 7 | 163 | 2 | DOID:2843 (is_implicated_in) | |
| Disease | invasive lobular carcinoma (is_marker_for) | 6.25e-04 | 7 | 163 | 2 | DOID:3457 (is_marker_for) | |
| Disease | Malignant Neoplasms | 7.41e-04 | 128 | 163 | 5 | C0006826 | |
| Disease | Uveal melanoma | 8.31e-04 | 8 | 163 | 2 | C0220633 | |
| Disease | Nonsyndromic genetic hearing loss | 8.45e-04 | 76 | 163 | 4 | cv:C5680182 | |
| Disease | X-12844 measurement | 1.06e-03 | 9 | 163 | 2 | EFO_0021339 | |
| Disease | ductal carcinoma in situ (is_marker_for) | 1.31e-03 | 39 | 163 | 3 | DOID:0060074 (is_marker_for) | |
| Disease | initial pursuit acceleration | 1.40e-03 | 87 | 163 | 4 | EFO_0008434 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 1.61e-03 | 11 | 163 | 2 | EFO_0800295 | |
| Disease | testosterone measurement | FAM184B SLC22A25 ANK2 MYO5A CYP3A4 ARHGAP26 TRAIP SLC22A24 LARP4 DDX6 IQGAP1 GGA3 COMMD4 FAM186A SYNE2 MYO15A | 1.93e-03 | 1275 | 163 | 16 | EFO_0004908 |
| Disease | methionine sulfone measurement | 1.93e-03 | 12 | 163 | 2 | EFO_0800072 | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 1.93e-03 | 12 | 163 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | 11beta-hydroxyandrosterone glucuronide measurement | 1.93e-03 | 12 | 163 | 2 | EFO_0800573 | |
| Disease | Papilloma | 1.93e-03 | 12 | 163 | 2 | C0030354 | |
| Disease | Papillomatosis | 1.93e-03 | 12 | 163 | 2 | C0205875 | |
| Disease | Papilloma, Squamous Cell | 1.93e-03 | 12 | 163 | 2 | C0205874 | |
| Disease | uric acid measurement | PRKD2 SESTD1 DNAH3 ARHGAP26 IFT81 HECTD4 SLC22A24 COMMD4 PIP5K1B HFM1 | 2.17e-03 | 610 | 163 | 10 | EFO_0004761 |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 2.27e-03 | 13 | 163 | 2 | EFO_0800284 | |
| Disease | Prostatic Neoplasms | REC8 ERBB2 ATP7B CYP3A4 CYP3A43 CCND1 TBL1XR1 ITPR1 SF3B1 APPL2 | 2.33e-03 | 616 | 163 | 10 | C0033578 |
| Disease | Malignant neoplasm of prostate | REC8 ERBB2 ATP7B CYP3A4 CYP3A43 CCND1 TBL1XR1 ITPR1 SF3B1 APPL2 | 2.33e-03 | 616 | 163 | 10 | C0376358 |
| Disease | Major Depressive Disorder | 2.38e-03 | 243 | 163 | 6 | C1269683 | |
| Disease | spontaneous preterm birth | 2.42e-03 | 101 | 163 | 4 | EFO_0006917 | |
| Disease | trimethylamine-N-oxide measurement | 2.64e-03 | 14 | 163 | 2 | EFO_0010541 | |
| Disease | response to cisplatin | 2.84e-03 | 51 | 163 | 3 | GO_0072718 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 2.84e-03 | 51 | 163 | 3 | cv:CN043650 | |
| Disease | C-reactive protein measurement | ZSWIM8 CYP3A4 TRAIP HID1 TBL1XR1 DDX6 MAPK8IP3 ITPR1 PKD1 CFAP45 OASL ZBTB40 HFM1 MAPK6 MYBPC3 | 2.90e-03 | 1206 | 163 | 15 | EFO_0004458 |
| Disease | hyperinsulinism (biomarker_via_orthology) | 3.04e-03 | 15 | 163 | 2 | DOID:2018 (biomarker_via_orthology) | |
| Disease | tumor necrosis factor beta measurement | 3.04e-03 | 15 | 163 | 2 | EFO_0008308 | |
| Disease | obsolete_red blood cell distribution width | MYO19 HECTD4 CDH23 TBL1XR1 SLC40A1 PTK2 IQGAP1 ARPC2 GAL NPRL2 TMEM259 SYNE2 VPS13A ZBTB40 HFM1 SEC23B | 3.32e-03 | 1347 | 163 | 16 | EFO_0005192 |
| Disease | Romano-Ward Syndrome | 3.46e-03 | 16 | 163 | 2 | C0035828 | |
| Disease | Chronic Lymphocytic Leukemia | 3.52e-03 | 55 | 163 | 3 | C0023434 | |
| Disease | lysophosphatidylcholine 18:1 measurement | 3.91e-03 | 17 | 163 | 2 | EFO_0010360 | |
| Disease | urate measurement | PRKD2 DNAH3 CYP3A4 MSANTD5 TRAIP RAB11FIP2 HECTD4 COMMD4 CSPG4 PIP5K1B HFM1 GJA10 | 4.21e-03 | 895 | 163 | 12 | EFO_0004531 |
| Disease | neutrophil count | SPATA6L MYCBP2 ARHGAP26 HECTD4 CDH23 ITPR2 ARPC2 ANKRD13A TIE1 FAM186A PKD1 CFAP45 PLCB4 PLCL1 MAPK4 MAP2K5 | 4.25e-03 | 1382 | 163 | 16 | EFO_0004833 |
| Disease | birth weight, parental genotype effect measurement | 4.36e-03 | 192 | 163 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | metabolonic lactone sulfate measurement | 4.88e-03 | 19 | 163 | 2 | EFO_0800659 | |
| Disease | Chronic myeloproliferative disorder | 4.88e-03 | 19 | 163 | 2 | C1292778 | |
| Disease | diet measurement, HOMA-B | 4.88e-03 | 19 | 163 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | age at onset, smoking initiation | 4.88e-03 | 19 | 163 | 2 | EFO_0004847, EFO_0005670 | |
| Disease | etiocholanolone glucuronide measurement | 4.88e-03 | 19 | 163 | 2 | EFO_0800362 | |
| Disease | Bipolar Disorder | 5.18e-03 | 477 | 163 | 8 | C0005586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EPVIMELERQENVLV | 376 | P16118 | |
| TMRRLLQETELVEPL | 686 | P04626 | |
| LLVERLGMTPAQIQA | 56 | Q8TE69 | |
| LLVERLGMTPAQIQA | 56 | Q96DE9 | |
| QAMVIVPTRELALQV | 166 | P26196 | |
| EQVAMELRLTPLTVL | 556 | O95696 | |
| ARIIRVILQSVPDMA | 201 | Q7RTX7 | |
| DQLVLEVSVTARVPM | 516 | Q6UVK1 | |
| DNLIIREEQVPMELV | 811 | P35670 | |
| LENITQLIPIIEAML | 526 | Q86UK0 | |
| MILLEVNNRIIEETL | 1 | O15144 | |
| VRQAALPIMELSQEL | 481 | Q969M2 | |
| LSLPQELQVARILMV | 71 | C9JDP6 | |
| PLQDMIERAIILVQT | 3526 | Q86UQ4 | |
| LQRLIVLEHRVMTIP | 1586 | Q5JWR5 | |
| SIRPEELLQMELLLV | 131 | P24385 | |
| VNLRPVVQLIDIMKD | 116 | Q5TGY3 | |
| LSELRPVTIVFVNLM | 286 | Q96PN6 | |
| ALLQAQVVMRIVDPE | 171 | P33240 | |
| QVVMRIVDPEIALKI | 176 | P33240 | |
| MLLVEVIDVNDNRPV | 2596 | Q9H251 | |
| IQVEIALAMQPLRSE | 476 | Q49A88 | |
| LVLRRTILPTQVENM | 346 | Q2TB18 | |
| LRQSLVMLQVLPQAV | 91 | Q5SZJ8 | |
| TVLPLVMDIQLLGQR | 151 | Q6GMV1 | |
| NALRQILAPVVKEIM | 1066 | P46940 | |
| LLVQLVPLMQVFVRL | 536 | Q9HC84 | |
| FVELLQMEQVRRIPE | 986 | Q68CQ1 | |
| QAMEEQLVSTLVPLL | 1121 | Q68CQ1 | |
| MEIVILPTETTINIQ | 1 | A0A3B3IT52 | |
| TLFDLVVPMILQQRA | 196 | Q9NX57 | |
| RAQLQIRIDMETELP | 101 | O95072 | |
| SERERLLPVINTMLQ | 1726 | Q99666 | |
| SERERLLPVINTMLQ | 1726 | O14715 | |
| TRTLLAILDIVQAPM | 886 | Q14571 | |
| IVRQDRSMEQIVFPV | 2126 | Q14573 | |
| VHLMETNTEPLQERI | 3646 | Q01484 | |
| EQVIPIIDLMARTSA | 376 | Q8IZ07 | |
| PVEEIQIIHMERLLI | 41 | Q8WTU0 | |
| TIPAALLDRMEIIQV | 496 | Q86WA8 | |
| VPVVTVVRAMLNNVV | 201 | Q9BUP3 | |
| VVKELMPLVVNVLEN | 51 | Q9UPT6 | |
| MPLVVNVLENLDSVL | 56 | Q9UPT6 | |
| IVRLDRTMEQIVFPV | 2206 | Q14643 | |
| VMQQIKILEATPLLE | 1341 | Q9UKN7 | |
| PEDVLLEMVQIRTIR | 341 | Q96H55 | |
| EAAQIIIDVLQLPMS | 56 | Q08623 | |
| EQMQLILETIPVIRE | 236 | P31152 | |
| IQVVLRVRPMSAAEL | 26 | Q96FN5 | |
| PEMQEVLLEVQRLRV | 191 | Q9ULE4 | |
| EIAEMLSQHQPIIRV | 491 | Q8IYD8 | |
| TEMDVQVRRVLQIPL | 391 | Q5JUK3 | |
| ATVLQLLQRQMTLVP | 1061 | Q12809 | |
| PETIQLITRDMVREL | 76 | Q9UL16 | |
| LDMVVNETLRLFPIA | 356 | P08684 | |
| LITTEALQMVQLRPV | 1071 | Q5SYE7 | |
| QEVRPLMAVEIIEQL | 31 | Q86YR7 | |
| IDVITMQTLVLLVDL | 206 | Q8NDV2 | |
| AMENQVLVIRIKIPN | 11 | Q13163 | |
| HELEQMQLILESIPV | 236 | Q16659 | |
| LVQTEEMQPVVFVLL | 26 | P47893 | |
| LVQTEEMQPVVFVLL | 26 | P47888 | |
| INIRIVVMNNVLPRS | 181 | O14986 | |
| EPVIMELERQENVLV | 371 | Q16875 | |
| VQLVTELRMTRAIQP | 741 | Q8IYU2 | |
| INVDVALTMPREILQ | 176 | Q9H6R4 | |
| ETAIRQALMPVILQD | 501 | Q9BZL6 | |
| VRMAPVITEETTLQL | 411 | O00566 | |
| RPDVLVVVVSMLNTA | 621 | Q9NZ52 | |
| LVEIILHVVRQMTDP | 76 | Q9UNM6 | |
| VFVANPLQERTILMR | 56 | Q9Y4D8 | |
| DQLAILLPVRLEMAV | 176 | O15529 | |
| PQSNIRNMVAVLEVI | 21 | O95402 | |
| ELSLLLQVEQRMPVS | 111 | Q8NB16 | |
| LSIVSEIQPQMLVEL | 656 | Q8TE96 | |
| LVQQILKTERVVIPM | 711 | P09884 | |
| ISIAQIRETPMVLEL | 311 | Q49AM1 | |
| MVLELTPQIVQYRIR | 321 | Q49AM1 | |
| LRMEQRVPDALVFTI | 126 | Q15646 | |
| VVFELAITRLLMEVP | 311 | A2PYH4 | |
| QLMVALRVRPISVAE | 11 | Q2TAC6 | |
| IVLLLTVLFRMQAQP | 396 | P11117 | |
| LQRMVLVDLPGVINT | 391 | O60313 | |
| RLVVLAIANTMDLPE | 646 | Q13415 | |
| RNIMNIIDIISIIPY | 301 | Q16322 | |
| TIMEVQRLTVVVPLA | 406 | Q7Z449 | |
| TVVNPIRMDEFRQII | 646 | Q9ULG6 | |
| ESVLVVQLEVLEMLR | 2321 | Q6WRI0 | |
| PMQLLQVLSDVLAEI | 31 | Q8WYA0 | |
| LDMVVNETLRLFPVV | 356 | Q9HB55 | |
| QLIMIKLEVSEPIIV | 486 | Q8TD57 | |
| RLSQLSIMEEVLIPD | 386 | Q9UKT7 | |
| IPENNIMRTIIEFLS | 81 | P22466 | |
| VQSLAQNPRLRMIVE | 336 | Q96RY5 | |
| DQLAILLPVRLEMAV | 176 | O14843 | |
| VMVRIREPLTAQQLE | 786 | Q6P1N0 | |
| QQLTMKPEEIVRLRE | 186 | Q5VVM6 | |
| VKIVMLVNENPLLTE | 176 | Q8IV38 | |
| QLADTMVLPIIQFRE | 106 | Q8NEU8 | |
| LLQSVEEPMVHLRLE | 146 | Q9H0A8 | |
| DLILEVLRSSPMVQV | 171 | Q71RC2 | |
| LPAILQQVRIQEMLL | 451 | Q4ZIN3 | |
| VSIMVANILRLFQIP | 161 | Q14831 | |
| RDVQETLMPQVLTTL | 696 | Q86Y56 | |
| PVINNLIQMILAEIE | 786 | A6NE01 | |
| LAIIFVPQEMQTLRV | 421 | Q6T423 | |
| VPQEMQTLRVVLATL | 426 | Q6T423 | |
| RLNIEMHAVVRITPV | 421 | O43933 | |
| ELLMVVSIVLERNPE | 1001 | Q93100 | |
| VNQTLRILVVSRNPM | 301 | Q6ZQY2 | |
| VDVVLPLQVLMRRSQ | 2151 | P98161 | |
| ITVMVVFLRDPQELL | 406 | P49593 | |
| RPIMQELLHIVRETE | 541 | O15397 | |
| QIRESLLQIPRIEMK | 301 | Q8NGK5 | |
| RRLTQLSVMEEVLIP | 391 | Q9UKT6 | |
| ATVEQVLDPRTRMIL | 156 | Q9BRS2 | |
| LRQELLAMIPIDQIL | 1046 | A6NKG5 | |
| DPLLILSQIVLMQTV | 11 | Q8N2H4 | |
| IVELVVNKMAQALPR | 406 | P17600 | |
| VPEILVHNIVIFMRT | 206 | Q9BVX2 | |
| LTTEVMQIRDFLPRI | 31 | O75031 | |
| PLLDLVVQLARDLQM | 106 | O75691 | |
| DNLLVRVMEETPNIL | 1256 | Q6WKZ4 | |
| RVMEETPNILRIPTQ | 1261 | Q6WKZ4 | |
| MPLEVVVELQIRAIS | 1 | Q8N4H0 | |
| IELIPQVRIEDLKQM | 911 | Q15147 | |
| LLQSSEIPLELQVME | 1706 | Q8WXH0 | |
| EIPLELQVMESSILN | 1711 | Q8WXH0 | |
| FQLMVQESETLIIPR | 2846 | Q8WXH0 | |
| LMQLEKELVERQPQV | 6706 | Q8WXH0 | |
| LPQEMQILRVVLATL | 426 | Q8N4F4 | |
| ATRQVLEELTELPVM | 401 | Q06210 | |
| NLVIIRTLLMQPVQQ | 206 | P25105 | |
| ERALPIQLTVQALDM | 901 | O94761 | |
| LLAIIFVPQEMQTLR | 421 | Q8IVM8 | |
| ISELLTPLQAELMRI | 426 | Q5SWL8 | |
| QVLPTHLMEERLIRQ | 801 | Q05397 | |
| TIMRLLQVLVPQVEK | 696 | Q8IV36 | |
| RVISELLTPLQAELM | 426 | A3QJZ6 | |
| YRMVQLEPIDQVVLS | 396 | P48764 | |
| RIRMIENASEVLITP | 101 | Q9UNA1 | |
| TIRRIDQLTNILAPM | 176 | Q9NP59 | |
| VLEKMLVIVVLPVRN | 1661 | O75592 | |
| QDILRMLLSLQPVLQ | 1276 | Q9UHV7 | |
| QKLVPIMTILLEELN | 126 | Q8WTW4 | |
| ELQMIQPEKLLLVTV | 31 | Q9P1W8 | |
| MLLPDENREVLQTLL | 1191 | Q96QB1 | |
| SIMLVVELVQRAPEQ | 1276 | Q7RTU9 | |
| LSLIDAVMPDVVQTR | 81 | Q9BZK7 | |
| RQDLTQSLIMIQPIL | 611 | Q15437 | |
| VVMLQNVVPAEVSLV | 81 | Q86VW0 | |
| VRVPLEILAMHENVL | 396 | O60284 | |
| VVIHEIQRLVDIVPM | 6 | Q6ZSU1 | |
| MVLESVARIVKVQLP | 1 | Q8N5K1 | |
| LQPVRETQIIMRIFL | 61 | Q8N614 | |
| MVALQIAREPLVRQV | 591 | Q7KZ85 | |
| AVIRLMVNLTQPALL | 81 | Q9UNS1 | |
| VNLPELAMIRFVVLD | 786 | Q15111 | |
| LLANVQVVLRPAVQM | 781 | Q7RTX0 | |
| RMALDINIKAPVVVI | 1206 | Q96RL7 | |
| TREVMLILIREFQSP | 766 | O75533 | |
| IVVDPSENVTLMNLR | 496 | P35590 | |
| LEPMERILEHIQILA | 166 | Q92670 | |
| ESLVQILQPQRRVDM | 391 | P08240 | |
| IDNLLVRVMEETPSI | 481 | Q7L804 | |
| LSLIVAVIPDVVQMR | 81 | Q9BQ87 | |
| VLQEIVMETLQRLSP | 1731 | A7E2V4 | |
| IIPAARVAIQTMEVS | 1311 | Q9UPU5 | |
| SILERLLQAMEPVHV | 66 | Q16401 | |
| ESIMLVVELVQRAPE | 1276 | A6NGW2 | |
| IQRLIDSVPLMNLLL | 521 | Q5T4S7 | |
| LNVALRVPSIMLLDV | 11 | Q96MT1 | |
| VDLVLELAPMSVLRV | 76 | Q6ZRP0 | |
| PMNVKNVVELLTIVQ | 256 | Q8N8C0 | |
| LIQCVTQLRPIMESL | 361 | Q9NUA8 | |
| ETAPQLTLVLAIMLQ | 141 | Q9H6D3 | |
| MEQIELLLQSQRPEV | 166 | Q9BWF2 | |
| LLLQSQRPEVEEMIR | 171 | Q9BWF2 | |
| IMEVIRNQEFLLLPA | 341 | Q9NR64 | |
| LDRMVVLLSVTVQQP | 1936 | Q9NR99 | |
| EARLILQLTVLEPME | 2526 | Q9NR99 | |
| LELPNNEIRVVSMQV | 406 | Q58DX5 | |
| QQLVRVLENILQPMI | 1611 | Q9Y4I1 | |
| ILRELVPENLTRLMS | 1956 | Q6PIF6 | |
| ITRPLEDQLVMVGQR | 456 | Q14896 |